"Somos uma subsidiária da Natco Pharma Limited, indústria Farmacêutica Indiana, uma das maiores produtoras de IFA's e que produz também medicamentos acabados do mundo. Presente nos EUA, Canadá, Austrália, Nova Zelandia, Índia e China, atualmente, estamos introduzindo no mercado Brasileiro diversos medicamentos genéricos inclusive exclusivos, para o tratamento oncológico, hematológico, prevenção de gripe influenza, prevenção de trombose e diabetes.
| Website | http://www.natcofarma.com |
| Revenue | $6.3 million |
| Employees | 104 (84 on RocketReach) |
| Founded | 2011 |
| Phone | +55 11 3568-2213 |
| Technologies |
JavaScript
,
HTML
,
PHP
+20 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing |
| Keywords | Generic Drugs, Healthcare, Pharmaceutical Manufacturing, Active Pharmaceutical Ingredients, Drug Supply, Quality Control, Finished Dosage Forms, Global Pharma, Regulatory Affairs, Drug Development, Api Manufacturing, Pharmaceutical Research, Drug Production, Fda Approved Drugs, Drug Formulation, Clinical Trials, Bioavailability, Drug Patents |
| Competitors | Eurofarma, Aché Laboratórios, EMS, Prati-Donaduzzi, Medley, Laboratorio Neo Quimica, Laboratório São Paulo, Biosintetica, Sandoz do Brasil Industria Farmaceutica Ltda., Gran Farma +21 more (view full list) |
Looking for a particular NATCOFARMA BRASIL employee's phone or email?
The NATCOFARMA BRASIL annual revenue was $6.3 million in 2026.
Eduardo Rocha is the CEO of NATCOFARMA BRASIL.
84 people are employed at NATCOFARMA BRASIL.